Virtus ETF Advisers’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,533
Closed -$70.8K 818
2024
Q4
$70.8K Buy
+1,533
New +$64.8K 0.03% 370
2021
Q4
Sell
-1,854
Closed -$124K 399
2021
Q3
$124K Sell
1,854
-96
-5% -$7.88K 0.05% 371
2021
Q2
$208K Buy
1,950
+96
+5% +$11.4K 0.09% 319
2021
Q1
$282K Buy
1,854
+33
+2% +$5.37K 0.12% 253
2020
Q4
$305K Buy
1,821
+650
+56% +$116K 0.13% 204
2020
Q3
$183K Sell
1,171
-159
-12% -$32K 0.1% 306
2020
Q2
$278K Sell
1,330
-40
-3% -$8.24K 0.13% 310
2020
Q1
$256K Sell
1,370
-199
-13% -$46.9K 0.11% 247
2019
Q4
$379K Buy
1,569
+14
+0.9% +$2.7K 0.06% 277
2019
Q3
$263K Sell
1,555
-86
-5% -$19.5K 0.05% 211
2019
Q2
$320K Buy
1,641
+737
+82% +$159K 0.07% 198
2019
Q1
$239K Sell
904
-119
-12% -$21.8K 0.51% 81
2018
Q4
$204K Buy
+1,023
New +$312K 0.03% 177

Other funds holding TECX

Virtus ETF Advisers's TECX Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Tectonic Therapeutic (TECX) in Q1 2025, closing a stake of 1,533 shares — an estimated $70.8K sold.

Virtus ETF Advisers first reported a position in TECX in Q4 2018 and held it in 13 quarters. The position peaked at $379K in Q4 2019. 78 funds tracked by Wall St. Rank hold TECX as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Tectonic Therapeutic position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,533 Tectonic Therapeutic shares in Q1 2025, an estimated $70.8K.
  • Virtus ETF Advisers first reported a position in Tectonic Therapeutic in Q4 2018 and held it in 13 quarters.
  • Virtus ETF Advisers's Tectonic Therapeutic position peaked at $379K in Q4 2019.
  • 78 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.